Trial · NCT07890220
Intravenous Dexamethasone for ESP Block Analgesia in Children Undergoing Idiopathic Scoliosis Surgery
NCT07890220, Phase 4, Not yet recruiting, Poznan University of Medical Sciences
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Intravenous Dexamethasone for ESP Block Analgesia in Children Undergoing Idiopathic Scoliosis Surgery. Trials, record NCT07890220. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07890220
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Intravenous Dexamethasone for ESP Block Analgesia in Children Undergoing Idiopathic Scoliosis Surgery
- NCT number
- NCT07890220
- Status
- Not yet recruiting
- Phases
- Phase 4
- Enrollment
- 90 participants, estimated
- Lead sponsor
- Poznan University of Medical Sciences
- Conditions
- Adolescent Idiopathic Scoliosis (AIS)
- Interventions
- Dexamethasone (0.1 mg/kg), Dexamethasone (0.2 mg/kg), Placebo
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cumulative Intravenous Fentanyl Consumption | 48 hours after surgery | Total cumulative dose of intravenous fentanyl administered during the first 48 hours after surgery, including continuous infusion and any additional rescue doses. Fentanyl consumption will be normalized to body weight and expressed as micrograms per kilogram (µg/kg). |
| Secondary | Postoperative Pain Intensity | 6 hours after surgery | Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity. |
| Secondary | Postoperative Pain Intensity | 12 hours after surgery | Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity. |
| Secondary | Postoperative Pain Intensity | 24 hours after surgery | Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity. |
| Secondary | Postoperative Pain Intensity | 48 hours after surgery | Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity. |
| Secondary | Cumulative Rescue Fentanyl Consumption | 48 hours after surgery | Total cumulative dose of additional intravenous fentanyl administered as rescue analgesia in addition to the continuous fentanyl infusion. Rescue fentanyl consumption will be normalized to body weight and expressed as micrograms per kilogram (µg/kg). |
| Secondary | Number of Rescue Fentanyl Doses | 48 hours after surgery | Number of additional intravenous fentanyl rescue doses administered for inadequate postoperative analgesia during the first 48 hours after surgery. |
| Secondary | Postoperative Nausea and Vomiting | 48 hours after surgery | Occurrence of postoperative nausea and/or vomiting during the first 48 hours after surgery. The need for rescue antiemetic medication will also be recorded. |
| Secondary | Perioperative Blood Glucose Concentration | 48 hours | Blood glucose concentration will be measured to assess dexamethasone-associated perioperative hyperglycemia. Glucose concentration will be recorded in mg/dL. |
| Secondary | Perioperative Blood Glucose Concentration | 12 hours | Blood glucose concentration will be measured to assess dexamethasone-associated perioperative hyperglycemia. Glucose concentration will be recorded in mg/dL. |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07890220
GET https://conductscience.org/api/trials/v1/NCT07890220/registered